WORLDREMIT
18.12.2020 10:02:12 CET | Business Wire | Press release
Today, WorldRemit , a leading cross-border payments company, celebrates International Migrants Day by announcing its list of the top 20 Migrant Moments of 2020. This list features developments which have had significant impacts on communities across the world. From the first COVID-19 vaccine to the US presidential election to SpaceX - each of these milestones have been influenced by migrants from around the world. 2020 marks the 20th anniversary of International Migrants Day and the 30th anniversary since the adoption by the UN General Assembly of the International Convention on the Protection of All Migrant Workers and Members of their Families1 .
WorldRemit has compiled this list to bring attention to all those who have managed to make a positive difference during this exceptionally challenging year. The company aims to support migrant communities as well as their family and friends every day, whilst celebrating their many successes throughout the year, and for many years to come.
The 2020 list includes:
- COVID-19 Vaccine: German couple of Turkish descent, husband and wife Uğur Şahin and Özlem Türeci, have been credited with the discovery of the Pfizer/BioNTech Covid-19 vaccine that is being distributed across the globe.
- Senator Kamala Harris: Kamala Harris became vice-president elect following the 2020 US Presidential election. In 2017, she was sworn in as a United States Senator for California, becoming the second African-American woman and first South-Asian American senator in history. Though she was born in Oakland, California, Harris’ parents emigrated to the United States from India and Jamaica.
- Future Stars: WorldRemit and Arsenal Football Club welcomed the winners of the Future Stars competition to London in January. Chinasa Mandy Ukandu of Nigeria and Luis Alejandro Castañeda from Colombia, won an all expenses paid trip to London to take part in a personalized training program with Arsenal Football Club’s Development coaches.
- Zoom boom: Zoom, the videoconferencing platform which has allowed friends, families and colleagues to stay in touch during Covid-19, was founded by Eric Yuan, a Chinese migrant to the United States. At its peak, the firm counted more than 300 million daily participants in virtual meetings, while paying customers have more than tripled.
- Project 8000: WorldRemit was the main sponsor of the Project 8000 programme in Singapore. Project 8000 is a community outreach initiative to give thousands of handwritten ‘thank you’ cards to frontline Covid-19 healthcare workers at the Tan Tock Seng Hospital (TTSH) in Singapore, led by student Marion Lee.
- Deliveroo and DoorDash: DoorDash, America’s most popular meal delivery app, was started by a Chinese American migrant, Tony Xu. Meanwhile Deliveroo was co-founded by William Shu, a Taiwanese American entrepreneur. DoorDash has launched a number of initiatives during the pandemic. In October, it launched the Reopen for Delivery campaign, with the stated aim of bringing together brick and mortar restaurants that have closed due to the pandemic.
- Patoranking: WorldRemit signed Patoranking as the Global Brand Ambassador for its Africa-focused WorldRemit Entrepreneurs Program. The WorldRemit Entrepreneurs Program will run simultaneously in Nigeria, Ghana, Kenya, and Zimbabwe, from November 2020 through to the end of January 2021. WorldRemit customers from around the world are encouraged to send a minimum of £50 (or its equivalent value in their local currency) to recipients in Nigeria, Ghana, Kenya, or Zimbabwe to win the opportunity to nominate a lucky entrepreneur.
- WorldRemit celebrated Philippine Independence Day by highlighting the many achievements of the Filipino diaspora which included one of the youngest ever recipients of the Royal Bank of Canada’s Top 25 Canadian Immigrant Award.
- Transfer Tracker app: WorldRemit launched The WorldRemit Transfer Tracker mobile app for recipients of money transfers, which allows them to track their remittances. The WorldRemit Transfer Tracker App is now available through the Google app store and is also free to download through the app store in 90 countries in iOS and Android.
- SpaceX Dragon 2: The spacecraft made its first crewed flight to the International Space Station on May 31, 2020 as part of the Commercial Crew Program, enabling American human orbital spaceflight capability for the first time since the Space Shuttle's retirement in 2011.
- Television Commercial: WorldRemit released global television commercials across key markets to promote its transparent pricing strategy and the opportunities created by connecting people through international money transfers.
- NHS workers: Almost 1 in 17 (14%) of the NHS’s 1.28 million staff report a non-British nationality, amounting to approximately 170,000 key workers. India is responsible for the most NHS workers from outside the UK, followed by the Philippines.
- Earlier this year, WorldRemit gave away £400,000 worth of vouchers to NHS workers as a token of appreciation for their service and the sacrifices they are making throughout the pandemic.
- Edward Enninful and Misan Harriman: Edward Enninful is the Editor-In-Chief of British Vogue and an advocate for better representation in the fashion industry. He is the only black editor in history to lead Vogue magazine. Enninful commissioned black photographer Misan Harriman to shoot Vogue’s UK September issue – traditionally the magazine’s most important edition. As well as being one of the most widely-shared photographers of the Black Lives Matter movement, Harriman is the first black person to shoot a cover of British Vogue in the magazine's 104-year history.
- Netflix launches Selena series: Netflix released its biographical drama that follows Selena Quintanilla Lopez’s rise to fame and the sacrifices she and her family make along the way charting her enduring legacy as a Mexican-American icon.
- David Olusoga: David Olusoga is a British-Nigerian historian and writer. In response to the Black Lives Matter movement, Olusoga's Black and British: A Forgotten History was broadcast on the BBC. The documentary was awarded a BAFTA when originally produced in 2016. Olusoga was also named on the 2021 Powerlist.
- Parasite: Parasite, a film written by South Korean native Bong Joon-ho, became the first non-English language film to win the Oscar for Best Picture in the 92-year history of the awards.
- Adewale Adeyemo: Among Biden’s team of top cabinet picks and economic advisers is Nigerian-born Adewale Adeyemo, who served as a senior international economic adviser in the Barack Obama administration. Adeyemo will be the first African to occupy the seat of Deputy Treasury Secretary.
- As part of efforts to create opportunities for those in developing countries, WorldRemit gave away tablets to students in countries including India and Guatemala following the pandemic-related disruption to schooling.
- A 90-year old lady named Margaret Keenan from Coventry, became the first person in the world to receive the Pfizer & BioNTech COVID-19 vaccine, which was administered by Filipina nurse May Parsons.
To learn more about WorldRemit, please visit www.worldremit.com .
WorldRemit
WorldRemit is a leading global payments company. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from 50 to 150 countries, operate in more than 5,000 money transfer corridors worldwide and employ over 1,200 people globally.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
________________
1
https://sdg.iisd.org/events/international-migrants-day-2020/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201218005131/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
